Parkinson's Disease Trial, By Invitation NCT06817772 Sponsor: Universidad Politecnica de Madrid Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT06817772
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Parkinson's disease based on a specific set of standard diagnostic guidelines known as the UK Brain Bank criteria.
  • People who are members of the Asociación Parkinson Madrid organisation.
  • People whose Parkinson's disease is at a minimal or mild stage, as measured by a standard rating scale called the Hoehn and Yahr scale, with a score of 2.5 or below.
  • People who are able to carry out the required exercises on their own, without assistance.
  • People who are able to manage their daily activities independently, without relying on a caregiver.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who score above 2.5 on the Hoehn and Yahr scale, indicating a more advanced stage of the condition.
  • People who have had a brain treatment called deep brain stimulation, who use a pump to deliver Parkinson's medication directly into the body, or who have a condition that causes similar symptoms to Parkinson's disease (such as progressive supranuclear palsy, Lewy body dementia, multiple system atrophy, or related conditions).
  • People who experience changes or fluctuations in their movement symptoms at different times throughout the day.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Universidad Politecnica de Madrid
Registry
ClinicalTrials.gov
Start date
9 December 2024
Est. completion
1 April 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Biomarkers for the identification of PD patients; biomarkers for the prediction MDS-UPDRS scores in PD patients; Biomarkers in supervised and unsupervised conditions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov